- Adjuvant Therapies for Early-Stage Breast Cancer
- CDK4/6 Inhibitors in HR+ mBC: Optimizing Treatment Selection
- Clinical Scenarios: CDK4/6i + ET in HR+ mBC
- Post-Frontline CDK4/6: How do you sequence in Advanced/Metastatic Breast Cancer?
- Reshaping Advanced or Metastatic Breast Cancer: Antibody-Drug Conjugates (ADC)
- Top Insights from SABCS 2024: HER2+ Breast Cancer
OncLive® State of the Science Summit™ Breast Cancer
Pendry Newport Beach
690 Newport Center Dr
Newport Beach, CA 92660
Wednesday, September 10, 2025
6:00 PM-9:00 PM PDT
Complimentary Parking
In-Person Only
Event Chair
Joanne Mortimer, MD, FACP, FASCO
City of Hope
OVERVIEW
OncLive® State of the Science Summit™ (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.
Registration for this Summit is complimentary.
TOPICS INCLUDE:
Venue Location
OncLive - an MJH Life Sciences brand
Copyright 2025 (C) Intellisphere, LLC
2 Commerce Drive
Cranbury, NJ 08512